At 4.7% CAGR, North America Automated External Defibrillators Market is Projected to be worth US$ 983.55 million by 2030, says Business Market Insights
According to Business Market Insights' research, the North America automated external defibrillators market was valued at US$ 681.03 million in 2022 and is expected to reach US$ 983.55 million by 2030, registering a CAGR of 4.7% from 2022 to 2030. Increasing prevalence of cardiovascular diseases and technological advancements are among the critical factors attributed to the North America automated external defibrillators market expansion.
There is a rise in technological advancements and increased investments in defibrillators by private players. In August 2022, Asahi Kasei (ZOLL) Medical Corporation introduced the Asahi Kasei (ZOLL) AED 4 defibrillator with integrated Wi-Fi connectivity for remote monitoring and data management, enhancing ease of use and maintenance. Similarly, in May 2023, Boston Scientific launched the EMPOWER External Defibrillator with smart features, including mobile app connectivity, patient education resources, and remote monitoring capabilities. In September 2019, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched the BeneHeart C Series of AEDs with intelligent operations and faster shock delivery to achieve better recovery outcomes for sudden cardiac arrest (SCA). The product range is available in fully automatic and semi-automatic versions that offer up to 360 Joules and are integrated with unique ResQNavi technology. Thus, the launch of new products due to the rise in technological advancements is leading to significant future trends in the automated external defibrillator market.
On the contrary, performance issues related to automated external defibrillators hamper the North America automated external defibrillators market.
Based on type, the North America automated external defibrillators market is bifurcated into fully-automated external defibrillators and semi- automated external defibrillators. The fully-automated external defibrillators segment held 69.6% share of North America automated external defibrillators market in 2022, amassing US$ 474.04 million. It is projected to garner US$ 671.19 million by 2030 to expand at 4.4% CAGR during 2022-2030.
Based on end user, the North America automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. The hospitals & clinics segment held 53.2% share of North America automated external defibrillators market in 2022, amassing US$ 362.09 million. It is projected to garner US$ 535.59 million by 2030 to expand at 5.0% CAGR during 2022-2030.
Based on country, the North America automated external defibrillators market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.1% share of North America automated external defibrillators market in 2022. It was assessed at US$ 565.98 million in 2022 and is likely to hit US$ 830.68 million by 2030, exhibiting a CAGR of 4.9% during 2022-2030.
Key players operating in the North America automated external defibrillators market are Asahi Kasei Corp, Koninklijke Philips NV, Mediana Co Ltd, Nihon Kohden Corp, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co Ltd, and Stryker Corp, among others.
In May 2023, Shenzhen Mindray Bio-Medical Electronics Co Ltd had signed a strategic agreement with Vithas. Under the agreement, Vithas integrated the latest innovative patient monitoring technology across its 20 hospitals. The strategic partnership enabled Vithas to improve patient safety in critical areas like ICU, operating rooms, post-anesthesia recovery, and emergencies.
In February 2022, Stryker Corp completed the acquisition of Vocera Communications Inc. This acquisition provided significant opportunities to advance innovations and accelerate Stryker's digital aspirations.
Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com
